North America Defibrillators Market Demand, Sales and Consumption Status and Growth Opportunities

External defibrillators and implantable cardioverter defibrillators (ICDs) are the two products in the North American defibrillators market. The ICD category is further bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). Among these two, T-ICD is expected to be the faster growing category in this market, advancing at a CAGR of 4.3% during the forecast period.

On the basis of end user, the North American defibrillators market is categorized into hospitals, clinics, and cardiac centers; public access settings; pre-hospital care settings; and home care settings. Public access settings as an end-user category is expected to observe fastest growth at a CAGR of 5.5% during the forecast period.

Request to Get the Sample Pages at:    https://www.psmarketresearch.com/market-analysis/north-america-defibrillators-market/report-sample

Given the growing awareness about the life-saving potential of defibrillators in case of emergencies, the installation of these devices is increasing in public places such as train stations, schools and colleges, shopping centers, airports, malls, and leisure centers. These defibrillators are also known as public access defibrillators (PADs), as they can be used by anyone during an emergency.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=north-america-defibrillators-market

In terms of value, the Canadian defibrillators market is predicted to grow at a CAGR of 4.3% during the forecast period. Increasing government support in the form of funding and initiatives to increase awareness and provide training on defibrillation; presence of a large number of local suppliers; and rising number of SCA cases have boosted the demand for defibrillators in Canada in the last few years.

The key players in the North American defibrillators market are Koninklijke Philips N.V., Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, Medtronic plc, BIOTRONIK SE & Co. KG, SCHILLER AG, Asahi Kasei Corporation, Defibtech LLC and Cardiac Science Corporation.